HIV drug resistance: brief report 2024
This brief report summarizes recent information on HIV drug resistance (HIVDR) in the era of integrase-strand transfer inhibitors (INSTI) for HIV prevention and treatment. In this report, WHO documents
This brief report summarizes recent information on HIV drug resistance (HIVDR) in the era of integrase-strand transfer inhibitors (INSTI) for HIV prevention and treatment. In this report, WHO documents
The Food and Drug Administration said on Thursday that recent data show patients taking H.I.V. drugs from GlaxoSmithKline and Bristol-Myers Squibb may have increased risk of heart attack.
Nearly five million people are living with HIV in Asia with 4,40,000 people dying each year.
Tuberculosis (TB) in Bhutan was well under control and in keeping with international standards, according to the programme manager for TB of the health ministry, Dr Pandup Tshering.